To measure IRF4 protein half‐life, we treated MM cell‐lines with 10 μg/ml cycloheximide to block protein synthesis for up to 72 h and monitored the effect on existing protein levels by western blotting (Figure 7A). The gene discussed is IRF4; the disease is Miyoshi myopathy.